"Nadolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
| Descriptor ID |
D009248
|
| MeSH Number(s) |
D02.033.100.624.698.601 D02.033.755.624.698.601 D02.092.063.624.698.601
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nadolol".
Below are MeSH descriptors whose meaning is more specific than "Nadolol".
This graph shows the total number of publications written about "Nadolol" by people in this website by year, and whether "Nadolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nadolol" by people in Profiles.
-
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy. Pacing Clin Electrophysiol. 2020 05; 43(5):527-533.
-
A large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2019 08; 42(8):1146-1154.